Anti-Counterfeit Technology Benefit To Pharma Could Reach $1 Bil. – HDMA

The financial return from adopting electronic product codes that use radio frequency identification to address Rx supply chain integrity would exceed the costs, a Healthcare Distribution Management Association report finds

More from Archive

More from Pink Sheet